DexCom Inc (DXCM)
68.99
-0.71
(-1.02%)
USD |
NASDAQ |
Nov 05, 16:00
69.01
+0.02
(+0.03%)
After-Hours: 20:00
DexCom Gross Profit Margin (Quarterly): 59.73% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.73% |
| June 30, 2024 | 62.40% |
| March 31, 2024 | 61.01% |
| December 31, 2023 | 63.47% |
| September 30, 2023 | 63.93% |
| June 30, 2023 | 62.71% |
| March 31, 2023 | 62.39% |
| December 31, 2022 | 66.40% |
| September 30, 2022 | 64.22% |
| June 30, 2022 | 64.56% |
| March 31, 2022 | 63.31% |
| December 31, 2021 | 67.69% |
| September 30, 2021 | 68.73% |
| June 30, 2021 | 70.09% |
| March 31, 2021 | 68.10% |
| December 31, 2020 | 70.15% |
| September 30, 2020 | 67.96% |
| June 30, 2020 | 62.88% |
| March 31, 2020 | 63.32% |
| December 31, 2019 | 66.83% |
| September 30, 2019 | 62.30% |
| June 30, 2019 | 61.39% |
| March 31, 2019 | 60.18% |
| December 31, 2018 | 65.92% |
| September 30, 2018 | 63.22% |
| Date | Value |
|---|---|
| June 30, 2018 | 63.34% |
| March 31, 2018 | 64.48% |
| December 31, 2017 | 69.46% |
| September 30, 2017 | 68.80% |
| June 30, 2017 | 68.87% |
| March 31, 2017 | 66.13% |
| December 31, 2016 | 68.17% |
| September 30, 2016 | 68.04% |
| June 30, 2016 | 62.27% |
| March 31, 2016 | 64.63% |
| December 31, 2015 | 69.72% |
| September 30, 2015 | 71.01% |
| June 30, 2015 | 70.82% |
| March 31, 2015 | 63.87% |
| December 31, 2014 | 70.46% |
| September 30, 2014 | 68.41% |
| June 30, 2014 | 67.86% |
| March 31, 2014 | 63.27% |
| December 31, 2013 | 65.96% |
| September 30, 2013 | 64.34% |
| June 30, 2013 | 61.17% |
| March 31, 2013 | 55.74% |
| December 31, 2012 | 52.85% |
| September 30, 2012 | 36.36% |
| June 30, 2012 | 47.86% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
59.73%
Minimum
Sep 2024
70.15%
Maximum
Dec 2020
64.99%
Average
64.07%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Orthofix Medical Inc | 67.84% |
| Abbott Laboratories | 55.83% |
| Bristol-Myers Squibb Co | 75.13% |
| Edwards Lifesciences Corp | 80.59% |
| Tandem Diabetes Care Inc | 50.83% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.96% |
| Return on Assets | 10.48% |
| Return on Invested Capital | 14.61% |
| Profit Margin (Quarterly) | 13.54% |
| Operating Margin (Quarterly) | 15.29% |
| Return on Net Operating Assets | 22.74% |